- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Galderma Group AG (GALD)
Assess today's live Galderma Group AG (GALD) share price, performance and insights using our live Switzerland: GALD stock exchange data.
Analyse the historical data and Galderma Group AG share price performance charts on this page. Our technical summary section provides analysis on Galderma share price buy/sell indicators using real-time data (or discuss the Galderma (GALD) stock price today with other investors in the Galderma SIX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SIX GALD share price (ISIN: CH1335392721) to enhance your trading decisions with our free investment tools and resources.
What Is the Galderma Group AG Share Price Today?
The Galderma share price today is 160.05.
What Is the Stock Symbol for Galderma Group AG
The stock symbol (or 'ticker') for Galderma Group AG is "GALD."
What Stock Exchange Does Galderma Group AG Trade On?
Galderma Group AG is listed and trades on the Switzerland stock exchange.
Is Galderma Group AG a Good Stock to Buy?
Determining whether Galderma Group AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Galderma Group AG share price performance charts on this page. Our technical summary section provides analysis on Galderma share price buy/sell indicators using real-time data (or discuss the Galderma (GALD) stock price today with other investors in the Galderma SIX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SIX GALD share price (ISIN: CH1335392721) to enhance your trading decisions with our free investment tools and resources.
What Is the Galderma Group AG Share Price Today?
The Galderma share price today is 160.05.
What Is the Stock Symbol for Galderma Group AG
The stock symbol (or 'ticker') for Galderma Group AG is "GALD."
What Stock Exchange Does Galderma Group AG Trade On?
Galderma Group AG is listed and trades on the Switzerland stock exchange.
Is Galderma Group AG a Good Stock to Buy?
Determining whether Galderma Group AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Currency in CHF
159.95
-1.55(-0.96%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
159.50
160.35
52 wk Range
107.40
171.90
GALD is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
159.50160.35
52 wk Range
107.40171.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GALD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
186.24
Upside
+16.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Galderma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Galderma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
14 Buy
3 Hold
1 Sell
Ratings:
18 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 186.24
(+16.43% Upside)
Galderma Group AG Earnings Call Summary for Q1/2026
- Galderma reported Q1 2026 net sales of $1.473B, up 25.5% YoY; EPS of $1.12 met expectations; stock surged 5.11% to $158.45
- Injectable Aesthetics generated $648M (13.1% growth); Dermatological Skincare reached $441M (17% growth), driving overall performance
- CEO Dittrich emphasized innovation and market expansion; incoming CFO La Corte highlighted strong financial position for growth opportunities
- Company issued optimistic 2026 guidance with projected EPS growth, new injectable aesthetics launches, and international market expansion planned
- Key risks include FX fluctuations impacting EBITDA, tariff pressures, market saturation, supply chain complexities, and competitive pressures
Last Updated: 23/04/2026, 15:38
Read Full TranscriptEarnings
Latest Release
23/04/2026
EPS / Forecast
0.23 / --
Revenue / Forecast
1.47B / 1.47B
Compare GALD to Peers and Sector
Metrics to compare | GALD | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipGALDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 77.6x | 25.2x | −0.5x | |
PEG Ratio | 0.47 | 0.44 | 0.00 | |
Price/Book | 5.8x | 3.4x | 2.6x | |
Price / LTM Sales | 9.1x | 4.1x | 3.0x | |
Upside (Analyst Target) | 18.8% | 14.0% | 58.6% | |
Fair Value Upside | Unlock | 10.7% | 10.2% | Unlock |
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Galderma (Switzerland: GALD) Share Price Today?
The Galderma stock price today is 159.95 CHF.
What Stock Exchange Does Galderma (GALD) Trade On?
Galderma is listed and trades on the Switzerland Stock Exchange.
What Is the Ticker (Stock Symbol) for Galderma?
The stock symbol (also called a 'ticker') for Galderma is "GALD."
Does Galderma Pay Dividends? What’s The Current GALD Dividend Yield?
Yes, GALD Pays Dividends to its Shareholders. The current Galderma dividend yield is 0.22%.
What Is the Current Galderma Market Capitalisation?
As of today, Galderma (Switzerland: GALD) market cap is 37.88B CHF.
What Is Galderma's (GALD) Earnings Per Share (TTM)?
The Galderma EPS is currently 2.58 (Trailing Twelve Months).
When Is the Next Galderma Earnings Date?
Galderma's next earnings report will be released on 23/07/2026.
Is GALD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Galderma moving averages and other technical indicators, the daily buy/sell signal for GALD stock is Buy.
How Many Times Has Galderma Stock Split?
Galderma has split 0 times. (See the GALD stock split history page for full effective split date and price information.)
How Many Employees Does Galderma Have?
Galderma has 7676 employees, based on their latest Companies House report.
What is the current trading status of Galderma (Switzerland: GALD)?
As of 08/06/2026, Galderma (GALD) is trading at a share price of 159.95 CHF, with a previous close of 161.50 CHF. The stock has fluctuated within a day range of 159.50 CHF to 160.35 CHF, while its 52-week range spans from 107.40 CHF to 171.90 CHF.
What Is Galderma (GALD) Price Target According to Analysts?
The average 12-month price target for Galderma is 186.24 CHF, with a high estimate of 263.81560057 CHF and a low estimate of 115.0095709 CHF. 14 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +16.43% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.